OSIS Stock Recent News
OSIS LATEST HEADLINES
NEW YORK , April 14, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of OSI Systems, Inc. ("OSI" or the "Company") (NASDAQ: OSIS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
I am initiating coverage on OSI Systems due to its strong revenue and earnings growth, combined with a reasonable valuation. OSIS has multiple key strategies that can drive long-term revenue and earnings growth. The company's effective offerings led to a strong, growing backlog.
LOS ANGELES--(BUSINESS WIRE)--OSIS Investors Have Opportunity to Join OSI Systems, Inc. Fraud Investigation with the Schall Law Firm.
NEW YORK CITY, NY / ACCESS Newswire / April 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of OSI Systems, Inc. ("OSI" or the "Company") (NASDAQ:OSIS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK , April 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of OSI Systems, Inc. ("OSI" or the "Company") (NASDAQ: OSIS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
OSI Systems, Inc.'s Security division drives growth with a record $1.8B backlog and global contract wins amid rising geopolitical demand. Strong execution supports raised FY25 guidance and robust revenue visibility. Elevated valuation reflects high expectations; policy risk and demand cyclicality warrant a cautious Buy rating for OSIS stock.
NEW YORK CITY, NY / ACCESS Newswire / April 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of OSI Systems, Inc. ("OSI" or the "Company") (NASDAQ:OSIS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of OSI Systems, Inc. ("OSI" or the "Company") (NASDAQ:OSIS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK CITY, NY / ACCESS Newswire / April 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of OSI Systems, Inc. ("OSI" or "the Company") (NASDAQ:OSIS). Investors who purchased OSI securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OSIS.
HAWTHORNE, Calif.--(BUSINESS WIRE)--OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced that its Healthcare division, Spacelabs Healthcare®, is expanding its footprint with an existing U.S.-based customer under an agreement to provide approximately $4 million of patient monitoring solutions and related supplies and accessories to the hospital. The agreement, which was facilitated in conjunction with a strategic partner, is part of Spacelabs' ongoing mission to fost.